New findings by Columbia researchers Dritan Agalliu, PhD, and David Sulzer, PhD, are showing that what triggers initial gastrointestinal changes in Parkinson’s could be a misdirected immune attack
Claassen, MD, FNCS, Professor of Neurology, conducted a study that could help doctors to identify patients with brain injuries, in seemingly unresponsive states, who are more likely to recover
Study led by Claassen, MD, FNCS, Professor of Neurology, suggests that patients with hidden consciousness can hear & comprehend verbal commands, but they cannot carry out them out
New study lead by Jan Claassen, MD, FNCS, Professor of Neurology and Chief of Critical Care and Hospitalist Neurology at NYP/CUIMC, has identified brain injuries that may underlie hidden consciousness
Carol M. Troy, MD, PhD, Professor of Pathology & Cell Biology and Neurology at CUMC, discusses, based on a new study, how eye drops could be more effective in treating retinal vein occlusion
Two inaugural awards in the field of neurodegeneration were announced today as part of the Carol and Gene Ludwig Center for Research on Neurodegeneration.
Dr. Lawrence S. Honig, Professor of Neurology at the CUIMC, comments on the significance of Food and Drug Administration approval of the Alzheimer’s disease drug, Lecanemab
Mitchell S.V. Elkind, MD, MS, MPhil, Professor of Neurology & Epidemiology, comments on the new study & recommendation of taking daily baby aspirin to help prevent first-time heart attack or stroke
Lawrence S. Honig, MD, PhD, Professor of Neurology at the CUIMC, an investigator for the study that led to the FDA’s approval of Leqembi expresses his opinions about the new Alzheimer’s Disease drug
